The Sarbanes-Oxley (SOX) Section 302 Sub-Certification Process: Driving Down Responsibility for Internal Controls
New Jersey NJ (PRWEB) September 15, 2008
The GRC Group, a global leader in governance, risk, and compliance, today announced it will sponsor a web seminar, "The Sarbanes-Oxley (SOX) Section 302 Sub-Certification Process: Driving Down Responsibility for Internal Controls," at 1:00 p.m. EDT on Thursday, September 25, 2008.
The 60-minute webinar will feature presenter Carol Cesareo, Associate Director of Financial Compliance at PharmaNet Development Group, Inc, who will cover the following key topics:
- Introduction to the 302 and 906 certification process
- Roll-Up Representation: The 302 sub-certification process and driving responsibility and accountability downward
- Internal Control Ownership: How far down is too far?
- How to implement the 302 sub-certification process
- Monitoring the success of 302 sub-certification process: Is it working?
Registration is free of charge to all members of The GRC Group, and is $45 for subscribers and non-members. Those interested in attending the Web seminar should register at http://www.grcg.com/webinar-september-2008.
As an initiative to re-establish investor confidence, the Sarbanes Oxley Act of 2002 made executive certifications of financial statements a permanent requirement applicable to all publicly traded companies in the U.S. Implementing a 302 sub-certification process is necessary for key employees with a significant internal control role so that the CEO and CFO have the highest degree of confidence in the information they receive.
According to Sanjay Anand, Chair of The GRC Group, "Ultimately, the 302 sub-certification process will allow the CEO and CFO to confidently sign off on the company certifications filed with the Securities Exchange Commission on a quarterly and annual basis".
About The GRC Group
The GRC Group offers its members the most comprehensive knowledge repository and certifications available in governance, risk, and compliance. Through its SOX Institute, GRC Institute, and IS/IT-GRC Institute, The GRC Group empowers its members with the expertise necessary to meet their formidable professional responsibilities today and in the coming years. Memberships are available at http://www.grcg.com.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,500 employees and 42 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at http://www.pharmanet.com.
For more information:
John Robert/Dennis O'Connor, Jr.
Paradigm Shift Communciations
1050 Winter Street Waltham MA
781.530.3700 Fax: 508.358.2515
Email: info @ paradigmshiftpr.com